Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00333047
NCT00333047
View on ClinicalTrials.gov
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
PHASE2/PHASE3
Completed
INTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
July 31, 2002
Conditions
Metastatic Breast Cancer
Interventions
DRUG
Letrozole
Trial Locations (1)
Unknown
Kiel
Sponsors
Lead Sponsor
Novartis
All Listed Sponsors
lead
Novartis
INDUSTRY
NCT00333047 - Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | Biotech Hunter | Biotech Hunter